Opioid Long-Term Effectiveness: FDA Postmarket Trial Design Offers ‘Best Compromise’

 
• By Brenda Sandburg
  
Opioid prescription
FDA panel to discuss postmarket clincial trial on long-term effectiveness of opioid analgesics • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers